Abstract:Background Heart failure (HF) is a syndrome due to cardiac insufficiency, manifested by excessive volume overload, increased sympathetic activity, and circulatory redistribution [1]. Heart failure with preserved ejection fraction (HFpEF) accounts for approximately 40%-50% of the total HF events, and its development is often accompanied by various complications, including hypertension, obesity, and metabolic syndrome. Biomarker associations in heart failure with reduced ejection fraction were mostly cardiac stretch based, while many biomarkers of HFpEF are also associated with inflammation [2]. To date, treatments that effectively improve the clinical prognosis of HFpEF are relatively limited, thus HFpEF remains one of the challenges that needs to be further explored. A full understanding of the molecular mechanisms of HFpEF is essential to improve the early diagnosis, treatment and prognosis of these patients. Purpose The study aims to explore key circulating miRNAs and related molecular pathways in HFpEF patients through bioinformatics analysis and machine learning, and to further validate them using a double-hit HFpEF mouse model. Methods We downloaded HF datasets including circulating miRNA expression profiles from the GEO database. LASSO regression, SVM-RFE, Random Forest and XGboost algorithm were conducted to identify key miRNAs for diagnostic model construction. We used R software, GO, KEGG and Cytoscape to better understand the functions of key miRNA targets. Besides, the mRNA-miRNA interaction networks were predicted by starbase. We also constructed a HFpEF mouse model subjected to high fat diet and L-NAME (0.5 g/L) in drinking water to discover the correlation between the screened circulating miRNA and HFpEF. Results After differential expression analysis of the combined HFpEF dataset, we identified 37 differentially circulating miRNAs, of which 15 were down-regulated and 22 were up-regulated. Subsequently, we screened by machine learning and identified 4 key miRNAs that may be involved in the progression of HFpEF, including hsa-miR-645, hsa-miR-296-5p, hsa-miR-199b-5p, and hsa-miR-509-3-5p. We validated these miRNAs based on their expression, and the ROC plots suggest that these miRNAs may have diagnostic capability in HFpEF. The results of GO and KEGG enrichment analyses showed that the target genes of the differentiated miRNAs were mainly enriched in the MAPK signaling pathway, mTOR signaling pathway, protein processing in endoplasmic reticulum, hippo signaling pathway, cell cycle, Foxo signaling pathway, hypertrophic cardiomyopathy, dilated cardiomyopathy, and circadian rhythm. The mRNA-miRNA interaction networks suggested that TMEM135 was regulated by both has-miR-199b-5p and hsa-miR-296-5p. The RT-PCR results also suggested that miR-199b-5p was upregulated in the HFpEF mice. Conclusion We validated 4 circulating miRNAs with strong correlation to HFpEF, which provide a more reliable basis for pre-symptomatic diagnosis.

miRNA-548c: a specific signature in circulating PBMCs from dilated cardiomyopathy patients

Expression of Mir-126 and Mir-508-5p in Endothelial Progenitor Cells is Associated with the Prognosis of Chronic Heart Failure Patients

Identification and Functional Prediction of Long Non-Coding RNAs in Dilated Cardiomyopathy by Bioinformatics Analysis

Circulating microRNAs as novel biomarkers for dilated cardiomyopathy.

Analysis of Changes in Circular RNA Expression and Construction of Cerna Networks in Human Dilated Cardiomyopathy.

Circulating microRNAs levels in Chinese heart failure patients caused by dilated cardiomyopathy

Distinct Circulating Expression Profiles of Long Noncoding RNAs in Heart Failure Patients with Ischemic and Nonischemic Dilated Cardiomyopathy.

Expression profiles and bioinformatic analysis of microRNAs in myocardium of diabetic cardiomyopathy mice

Abstract 13856: Circulating Microrna Differentiates HFpEF and HFrEF Patients

Circulating cardiac MicroRNAs safeguard against dilated cardiomyopathy

Differential Expression Profiles of Plasma Exosomal Micrornas in Dilated Cardiomyopathy with Chronic Heart Failure.

Circulating and Cardiac Tissue miRNAs in Children with Dilated Cardiomyopathy

Expression changes and significance of miR-155 in peripheral blood mononuclear cells of patients with dilated cardiomyopathy

Circulating miR-30d Predicts Survival in Patients with Acute Heart Failure.

Identification and validation of circulating microRNAs as biomarkers for heart failure with preserved ejection fraction

Differential Role of Circulating microRNAs to Track Progression and Pre-Symptomatic Stage of Chronic Heart Failure: A Pilot Study

Identification of microRNAs associated with heart failure with reduced ejection fraction

Combination of PBMC Mir-19B-5p, Mir-221, Mir-25-5p and Hypertension Correlates with Increased Risk of Heart Failure in Coronary Heart Disease Patients

Abstract P2013: Genomic Identification of Key CircRNAs in Healthy and Dilated Cardiomyopathy Human Heart

Signature Of Circulating Micrornas As Potential Biomarkers In Vulnerable Coronary Artery Disease

Circulating Mir-185 Might Be a Novel Biomarker for Clinical Outcome in Patients with Dilated Cardiomyopathy